Hydrolases TRIZ Cases

Engineered Cas9 variants with specific HNH domain mutations enhance genome editing precision through targeted amino acid substitutions.

Integrating nuclease toolboxes into specific cell loci eliminates external injection steps, resolving low genetic manipulation efficiency in large animals.

Integrating the ARO10* gene into five specific E. coli sites boosts tyrosol yield to 32.3 mM, surpassing the 10.6 mM limit of chemical synthesis methods.

Engineered recombinant microorganisms express heterologous dehydrogenases to produce lipids using inorganic carbon as a sole feedstock.

A short-chain guide RNA induces site-specific editing using a segmented oligonucleotide structure.

Engineered effector proteins with guide nucleic acids enable precise nucleic acid detection at elevated temperatures.

Defined synthetic peptide coatings replace undefined serum and feeder layers to expand mesenchymal stem cells while eliminating batch variability.

Friable embryogenic callus maintained under dim light overcomes tissue culture recalcitrance, enabling efficient targeted genome modifications.

Combining CAR-T specificity with NK innate killing overcomes solid tumor targeting limitations.

CRISPR-Cas systems record cellular events as permanent DNA modifications, resolving the loss of temporal information in single-cell profiling.

Inhibiting nonhomologous end joining pathways with small molecules or siRNA shifts cellular repair balance toward high-fidelity homologous directed repair.

Encapsulating enzyme crystals within water-soluble films protects biological catalysts from harsh detergent ingredients, resolving storage stability issues.

Replacing transgenic hormone pathways with CRISPR editing of endogenous PUF genes resolves yield complexity by enabling fine-tuned genetic modifications.

Truncated guide RNAs repress non-homologous end joining enzymes to resolve low homology-directed repair efficiency in vivo.

Endogenous expression of signaling molecules eliminates expensive exogenous protein supplementation, lowering production costs for cultured meat.

HiUGE and RMCE generate stable cell lines with precise genetic modifications, reducing time and effort required for characterization.

CRISPR knockout of TMPRSS2 and TMPRSS4 proteins eliminates host cell susceptibility to influenza and PEDV infections.

Engineered Aspergillus fumigatus lysophospholipase polypeptides maintain activity at 65°C to improve syrup filterability and clarity.

Synthetic modified mRNA delivers dCas9 proteins to avoid viral vector immune activation and toxicity risks.

Segmenting the Box A region isolates catalytic activity, resolving enzyme instability under humidity and temperature variations.

Adenine base editors correct the c.1222C>T mutation in the phenylalanine hydroxylase gene to restore wild-type enzyme function.

CasJ proteins utilize guide RNAs to achieve precise genome editing and diagnostic detection, resolving adaptability versus reliability trade-offs.

Computational design creates enzyme catalysts that stabilize transition states, resolving the trade-off between catalytic activity and design complexity.

TALEN-mediated FUT8 knockout in CHO cells eliminates fucosylation to resolve glycosylation heterogeneity and enhance ADCC activity.

Segmented RP-HPLC analysis identifies pancreatin enzymes to ensure batch consistency without excessive complexity.

Ligating partially complementary RNA fragments into stem-loop structures improves guide RNA purity and yield by avoiding low coupling efficiency side products.

Dual plasmid CRISPR-Cas9 system eliminates residual DNA traces while reducing experimental cycle time to three days for Salmonella genome modification.

Engineered Cas12i nuclease with targeted amino acid mutations improves gene editing efficiency in mammalian cells.

Specific deletions in Cas9 reduce protein size to fit adeno-associated virus vectors, enabling efficient in vivo delivery and customization.

Covalent boronic acid bonding anchors fragmented RNA to a polymerized matrix, preventing analyte loss during sample preparation.

A three-liquid phase system separates optically pure chiral products from racemic mixtures using lipase catalysis.

Removing plastid targeting sequences from plant linalool synthases stabilizes expression in brewing yeast, enabling detectable linalool concentrations.

Transgenic plants expressing the ACh1 protein eliminate chemical pesticide use, resolving environmental pollution while maintaining effective pest control.

Site-specific endonucleases target chloroplast DNA to generate stable non-photosynthetic mutants, enabling markerless transformation of agronomic traits.

An uncapped RNA guide directs Cas9 endonuclease to specific yeast chromosomal targets, resolving low gene targeting efficiency.

Synthetic transcription regulators control fertility genes to induce male sterility, avoiding mitochondrial damage and preserving plant resistance.

A virus delivers polynucleotide sequences into a genome using site-specific nucleases to generate double-strand breaks for precise insertion.

Pre-assembled ribonucleoprotein complexes eliminate plasmid synthesis and cloning steps, accelerating multiplex knockout processes in host cell lines.

Sequential prehydrolysis, delignification, and bleaching stages reduce silica content below 0.05% in sugarcane bagasse cellulose.

Evaluating Ago2 binding efficiency determines RNAi potency without complex cellular competition assays.

Exogenous nucleotides modulate ectoapyrase activity to precisely control cotton fiber length and cell wall deposition.

Whole cell enzyme reagents eliminate costly protein purification bottlenecks by delivering active enzymes directly into nucleic acid manipulation workflows.

Brainstem organoids with PHOX2B mutations replicate human respiratory defects to enable precise therapeutic discovery.

Combining geminiviral replication with customizable endonucleases overcomes low targeting efficiency and specialized equipment requirements.

Double irradiation with UVC and ionizing radiation reduces coagulation factors in platelet lysate while retaining growth factors.

Microbial cutinases degrade recalcitrant Nylon 6 polymers into caprolactam, solving low recycling rates.

Complementary inhibitor oligonucleotides bind guide RNA and crRNA to reduce genomic editing at unintended target sequences.

Hepatic portal vein injection of sgRNA plasmids bypasses slow embryonic stem cell methods to build primate tumor models quickly.

Optimized electroporation delivers base editors into primary human natural killer cells, resolving the trade-off between editing efficiency and cell viability.

Engineered nucleic acids targeting long non-coding RNAs activate interferon pathways, addressing limited therapeutic options for respiratory viruses.